CNBT
TNXP icon

Cornerstone National Bank & Trust’s Tonix Pharmaceuticals TNXP Stock Holding History

Cornerstone National Bank & Trust’s Portfolio TNXP Stock Details TNXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$41.4K Hold
3,330
– – 0.01% 134
2026
Q1 		$45.6K Hold
3,330
– – 0.02% 122
2025
Q4 		$52K Hold
3,330
– – 0.02% 103
2025
Q3 		$80.5K Hold
3,330
– – 0.03% 81
2025
Q2 		$120K Hold
3,330
– – 0.05% 73
2025
Q1 		$59.5K Buy
+3,330
New +$67.5K 0.03% 85

Other funds holding TNXP

Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
SIC
SJS Investment Consulting Sylvania, Ohio $919M AUM 23.4% 1-Year Est. Return
LSA
Leonteq Securities AG Zurich, Switzerland $2.91B AUM 56.5% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
EWA
EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
SCM
Sterling Capital Management Charlotte, North Carolina $5.9B AUM 29.63% 1-Year Est. Return

Cornerstone National Bank & Trust's TNXP Position: Q2 2026 in Review

Cornerstone National Bank & Trust held its Tonix Pharmaceuticals (TNXP) position steady in Q2 2026 at 3,330 shares worth $41.4K. The position accounts for 0.01% of the portfolio, ranked #134.

Cornerstone National Bank & Trust first reported a position in TNXP in Q1 2025 and has held it in 6 quarters since. The position peaked at $120K in Q2 2025. 19 funds tracked by Wall St. Rank hold TNXP as of Q2 2026.

  • Cornerstone National Bank & Trust held 3,330 shares of Tonix Pharmaceuticals worth $41.4K as of Q2 2026.
  • Cornerstone National Bank & Trust left its Tonix Pharmaceuticals share count unchanged in Q2 2026.
  • Tonix Pharmaceuticals made up 0.01% of Cornerstone National Bank & Trust's portfolio in Q2 2026, its #134 holding.
  • Cornerstone National Bank & Trust first reported a position in Tonix Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
  • Cornerstone National Bank & Trust's Tonix Pharmaceuticals position peaked at $120K in Q2 2025.
  • 19 funds tracked by Wall St. Rank held Tonix Pharmaceuticals as of Q2 2026.

Based on Cornerstone National Bank & Trust's 13F filing for Q2 2026, filed 21 Jul 2026.